The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples